Efficacy of Low‐Dose Oral Isotretinoin Combined With Fractional Microneedle Radiofrequency Versus Low‐Dose Oral Isotretinoin Monotherapy in the Treatment of Moderate‐To‐Severe Acne Vulgaris: A Randomized Controlled Comparative Study
Lasers in Surgery and Medicine · 2026-04 · 58 (4) · 321-330
DOI: 10.1002/lsm.70120 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 04.03.2026. Verfasst von Wareeporn Disphanurat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, Thammasat University, Pathum Thani, Thailand. Hauptthemen laut MEDLINE: Acne Vulgaris, Isotretinoin, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Thammasat University Research.
Abstract (Originalsprache)
Background and Objective Oral isotretinoin is the standard therapy for severe acne. However, scarring may persist. Fractional microneedling radiofrequency (FMRF) improves both inflammatory lesions and scars with minimal downtime. In this study, we compare isotretinoin monotherapy and concurrent isotretinoin and FMRF for active acne regarding clinical outcomes.
Methods
In this parallel two‐group comparative study, patients received either low‐dose isotretinoin monotherapy for 20 weeks ( n = 34) or low‐dose isotretinoin concurrently with 5 monthly FMRF sessions ( n = 36). Outcomes were assessed at baseline and weeks 12, 20, 24, 32, and 44. The primary endpoints were Global Acne Grading System (GAGS) scores and inflammatory/non‐inflammatory lesion counts. Secondary endpoints were hemoglobin indices and skin roughness.
Results
The GAGS scores of isotretinoin and FMRF were significantly lower than those of isotretinoin monotherapy from weeks 12–44 (−79.69% vs. −60.34% at week 44, respectively; p < 0.001). Isotretinoin and FMRF showed significantly greater lesion count reductions than isotretinoin monotherapy at follow‐up visits from weeks 12–44. Isotretinoin and FMRF showed significantly lower hemoglobin levels than isotretinoin monotherapy at weeks 32 and 44 ( p = 0.029 and p < 0.001, respectively). Skin surface roughness improved substantially and persistently from week 12–44.
Conclusions
Early active treatment with isotretinoin and FMRF is safe and better than isotretinoin monotherapy over 44 weeks regarding severity, reduced erythema, and improved surface roughness in moderate‐to‐severe acne vulgaris. This encourages early and effective treatment of acne to mitigate acne scarring and improve patients' quality of life. Clinicaltrials.gov (Or Equivalent) Listing: Thai Clinical Trials Registry (TCTR20250202008).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Department of Medicine, Thammasat University, Pathum Thani, Thailand.
ORCID-Profile: Wareeporn Disphanurat
Förderung
- Thammasat University Research
Zitieren
APA
Disphanurat, W., Leeyangyuen, P., & Srisantithum, B. (2026). Efficacy of Low‐Dose Oral Isotretinoin Combined With Fractional Microneedle Radiofrequency Versus Low‐Dose Oral Isotretinoin Monotherapy in the Treatment of Moderate‐To‐Severe Acne Vulgaris: A Randomized Controlled Comparative Study. Lasers in Surgery and Medicine, 58(4), 321-330. https://doi.org/10.1002/lsm.70120
Vancouver
Disphanurat W, Leeyangyuen P, Srisantithum B. Efficacy of Low‐Dose Oral Isotretinoin Combined With Fractional Microneedle Radiofrequency Versus Low‐Dose Oral Isotretinoin Monotherapy in the Treatment of Moderate‐To‐Severe Acne Vulgaris: A Randomized Controlled Comparative Study. Lasers in Surgery and Medicine. 2026;58(4):321-330. doi:10.1002/lsm.70120
BibTeX
@article{Disphanurat2026,
author = {Disphanurat, Wareeporn and Leeyangyuen, Pornpirun and Srisantithum, Benjaporn},
title = {Efficacy of Low‐Dose Oral Isotretinoin Combined With Fractional Microneedle Radiofrequency Versus Low‐Dose Oral Isotretinoin Monotherapy in the Treatment of Moderate‐To‐Severe Acne Vulgaris: A Randomized Controlled Comparative Study},
journal = {Lasers in Surgery and Medicine},
year = {2026},
volume = {58},
number = {4},
pages = {321--330},
doi = {10.1002/lsm.70120}
}
EUVIMED